An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
- 12 August 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Critical Reviews in Toxicology
- Vol. 41 (10), 803-821
- https://doi.org/10.3109/10408444.2011.602662
Abstract
Cisplatin is among the most effective chemotherapeutic agents against solid tumors. Nephrotoxicity is the most common side effect of cisplatin chemotherapy, which limits the clinical use of cisplatin and seriously worsens the quality of life of cancer patients resulting in dosage reduction and discontinuation of treatment. Cisplatin involves a complex multifactorial process, as it has direct toxic effect on cells of the renal tubules, vasculature and glomeruli, and causes alterations in renal blood flow and glomerular filtration rate. Indirectly, cisplatin also induces inflammation of the renal interstitium, which contributes to the acute damage and may lead to chronic interstitial fibrosis, indicative of irreversible renal damage. This review presents an integrative view of the pathophysiological effects of cisplatin on tubular, vascular, glomerular, and interstitial function and the interplay among these actions. Moreover, it reviewed human clinical trials of the last ten years in order to evaluate the incidence and severity of the renal injury induced by cisplatin at the doses and therapeutic guidelines used in the clinical practice.Keywords
This publication has 100 references indexed in Scilit:
- Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathyFree Radical Biology & Medicine, 2010
- Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factorsEuropean Journal Of Cancer, 2009
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced NephrotoxicityClinical Pharmacology & Therapeutics, 2009
- Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damageLife Sciences, 2009
- Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancerBritish Journal of Cancer, 2008
- Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicityBiochemical Pharmacology, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Naringenin attenuates cisplatin nephrotoxicity in ratsLife Sciences, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003